企業プロフィール
Guardant Health 株価・ニュース・カタリスト
- ティッカー:
- GH
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
161.67 USD (+2.84%)
終値
最終更新: 2026年8月17日
17.3B USD
時価総額
株価変動の要因
As of Aug 17, 2026, GH closed up 2.84% at $161.67. No new same-company headline was identified in the current news window.
企業概要
事業概要
Guardant Health is a liquid-biopsy company focused on oncology diagnostics for screening, therapy selection, and disease monitoring.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Guardant sits in precision diagnostics.
ビジネスモデルの特徴
The business depends on test adoption, reimbursement, clinical utility, and the expansion of liquid biopsy into more use cases.
バイオ業界での位置付け
Guardant is a leading oncology-diagnostics platform whose stock moves on adoption, reimbursement, and product performance.
今後のカタリスト
- Guardant Health's catalysts are Shield screening adoption, Reveal MRD traction, and any reimbursement or launch step that widens the oncology-diagnostics franchise. The company improves when screening and monitoring become more routine in clinical workflows.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。